Drug
Elagolix
Elagolix: highest development phase Phase 3, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| Elagolix NCT02691494 | Phase 3 | Uterine Fibroids |
Latest
No recent events.
Follow Elagolix on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.